Download Sample Brochure @ http://tinyurl.com/h8buzmp “Alzheimer's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. Read Analysis @ http://www.marketintelreports.com/report/diir2016109/Alzheimer’s Diseaseglobal-api-manufacturers-marketed-and-phase-iii-drugs-landscape-2016

1. Alzheimer's Disease-Global API Manufacturers,
Marketed and Phase III Drugs Landscape, 2016
“Alzheimer's Disease-Global API Manufacturers, Marketed and Phase III Drugs
Landscape, 2016”, provides comprehensive insights about the marketed drugs,
drug sales, Phase III pipeline drugs and their API Manufacturers across the globe.
Published on - 01 January, 2016 | Number of pages : 100
Single User Price: $2000

2. A key objective of the Alzheimer's Disease Report is to understand the market
and pipeline status of the drugs around the Alzheimer's Disease to explore the
generic development opportunities, licensing opportunities and to gain
competitive advantage on designing pipeline strategies. The Alzheimer's Disease
Report provides the historical and forecasted sales of the drugs till 2018.
The Report gives insights into patents providing the patent protection data and
marketing exclusivity of all the drugs across the Alzheimer's Disease. While the
leading brands, companies and chemicals are considered thoroughly, the report
also provides details on the Global API Manufacturers across the globe covering
Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China
and India.
Click Here To Check Complete Report

3. Scope of Report:
A snapshot of the global Market and Phase III therapeutics scenario for
Alzheimer's Disease.
A review of the marketed products under prescription for Alzheimer's
Disease, regulatory information and marketing status.
Coverage of global patent coverage and detailed commentaries on the US
patent challenges.
Graphical representation of investigational products for patent expiry and
market exclusivities across the globe.
Product profiles for marketed products for Alzheimer's Disease with
complete description of mechanism of action, therapeutic class, target,
route(s) of administration and chemical details.

4. Coverage of API Manufacturers for Alzheimer's Disease drugs in the United
States, Europe and Asian Regions with location details.
Coverage of Regulatory filings in the US, Europe, and Asia specifically India
and China for Alzheimer's Disease drugs.
Coverage of Route of Synthesis of Active Pharmaceutical Ingredient
associated with Alzheimer's Disease drugs.
Coverage of Alzheimer's Disease Phase III pipeline products featuring
sections on product description, mechanism of action, Chemical details and
research & development progress.
Coverage of the United States Drug Master File (US DMF) available for
Phase III Pipeline Drugs.
Key discontinued Marketed products.
Global Sales Figure to 2018.
Download Sample Brochure

5. Reasons to buy:
Evaluate the marketing status and exclusivity details of Alzheimer's Disease
key products to exploit opportunities for generic drug development
opportunities.
Identify and understand important and diverse types of therapeutics under
Phase III development for Alzheimer's Disease.
Design effective counter-strategies to gain competitive advantage by
identifying the key patent expiry details and exclusivity with respect to
Alzheimer's Disease.
API intelligence over marketed drugs for Alzheimer’s Disease and gaining
primary intelligence over active ingredients manufacturers across the globe.
API intelligence over leading Phase III Pipeline drugs.

6.  Develop and design strategies by identifying the API manufacturers for
Phase III Pipeline products to enhance and expand business potential and
scope.
 Understanding the scope of the Phase III Drugs with nil regulatory filings.
 Understanding the chemical route of synthesis of approved drugs for
Alzheimer's Disease.
 Uncovering opportunities in the rapidly growing US market.
Make an Inquiry Before Buying

7. Alzheimer's Disease-Global API Manufacturers, Marketed
and Phase III Drugs Landscape, 2016
A detailed qualitative analysis of the factors responsible for driving and restraining
growth of Alzheimer's Disease-Global API Manufacturers, Marketed and Phase III Drugs
Landscape, 2016 and future opportunities are provided in the report.
Contact:
1-302-684-6088
sales@marketintelreports.com
www.marketintelreports.com
Click here to order a copy of Alzheimer's
Disease Market Report